Baldwin Investment Management’s Immunome IMNM Stock Holding History

Baldwin Investment Management’s Portfolio IMNM Stock Details IMNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$538K	Hold	25,394	–	–	0.05%	159
2026 Q1	$570K	Sell	25,394 -21,773	-46%	-$485K	0.07%	147
2025 Q4	$1.01M	Buy	47,167 +21,773	+86%	+$382K	0.11%	110
2025 Q3	$297K	Hold	25,394	–	–	0.03%	182
2025 Q2	$236K	Hold	25,394	–	–	0.03%	196
2025 Q1	$171K	Hold	25,394	–	–	0.02%	199
2024 Q4	$270K	Hold	25,394	–	–	0.04%	180
2024 Q3	$371K	Hold	25,394	–	–	0.05%	172
2024 Q2	$307K	Hold	25,394	–	–	0.04%	177
2024 Q1	$627K	Hold	25,394	–	–	0.09%	136
2023 Q4	$272K	Hold	25,394	–	–	0.04%	180
2023 Q3	$212K	Hold	25,394	–	–	0.04%	185
2023 Q2	$201K	Hold	25,394	–	–	0.03%	195
2023 Q1	$127K	Hold	25,394	–	–	0.02%	198
2022 Q4	$56.1K	Hold	25,394	–	–	0.01%	195
2022 Q3	$113K	Hold	25,394	–	–	0.02%	197
2022 Q2	$82K	Hold	25,394	–	–	0.02%	215
2022 Q1	$144K	Buy	+25,394	New	+$190K	0.02%	241
2021 Q4	–	Sell	-9,196	Closed	-$224K	–	259
2021 Q3	$224K	Buy	+9,196	New	+$160K	0.04%	231
2021 Q2	–	Sell	-25,394	Closed	-$860K	–	256
2021 Q1	$860K	Buy	+25,394	New	+$631K	0.16%	111

Other funds holding IMNM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Baldwin Investment Management's IMNM Position: Q2 2026 in Review

Baldwin Investment Management held its Immunome (IMNM) position steady in Q2 2026 at 25,394 shares worth $538K. The position accounts for 0.05% of the portfolio, ranked #159.

Baldwin Investment Management first reported a position in IMNM in Q1 2021 and has held it in 20 quarters since. The position peaked at $1.01M in Q4 2025. 203 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

Baldwin Investment Management held 25,394 shares of Immunome worth $538K as of Q2 2026.
Baldwin Investment Management left its Immunome share count unchanged in Q2 2026.
Immunome made up 0.05% of Baldwin Investment Management's portfolio in Q2 2026, its #159 holding.
Baldwin Investment Management first reported a position in Immunome in Q1 2021 and has held it in 20 quarters since.
Baldwin Investment Management's Immunome position peaked at $1.01M in Q4 2025.
203 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Baldwin Investment Management's 13F filing for Q2 2026, filed 28 Jul 2026.